Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: No mention of costs The story quantifies the benefits in terms of survival for both intravenous and intraperitoneal chemotherapy. The story gives us balanced information on harms, including the very serious side effects which led to less than half the study population adhering to the full course of chemo. The story accurately represents the nature of the clinical evidence, that this was a controlled trial with 415 women. It should have been more clear that it was a randomized trial. The story accurately represents the prevalence of ovarian cancer and the survival. Independent source is quoted. The author does mention intravenous chemotherapy as the alternative and explains the advantages and disadvantages of the new approach. Clearly this treatment is available in the U.S., but it’s not clear how widely available it is and how many oncologists have experience using it. The story does not mention if the treatment is new or not.
[A]: Treatment brings hope for ovarian cancer


[Q]: The Alabama Department of Public Health announced the 2018 infant mortality rate was the lowest in Alabama history with 7.0 deaths per 1,000 live births It is an improvement over the 2017 rate of 7.4 and the 2016 rate of 9.1. “I am committed to improving the health of mothers and babies, and I am glad to see the infant mortality rates in 2017 and 2018 have improved from the rates earlier in this decade,” Gov. Kay Ivey said in a statement. However, Alabama’s mortality rate remains higher than the provisional U.S. rate of 5.7. “The continuing decline in Alabama’s infant mortality is a start to closing the historically large gap between the state and national rates,” Alabama Center for Health Statistics Director Nicole Rushing said. A total of 405 infants born in 2018 in Alabama died before reaching their first birthday. There also remains a racial disparity in infant mortality rates. The infant mortality rate for black infants in Alabama was 11.0 in 2018, more than twice the infant mortality rate for white infants at 5.1. State Health Officer Scott Harris said the the reduction in infant mortality is encouraging, but the state must continue to address Alabama’s racial disparities in birth outcomes, increase access to prenatal care and getting treatment for women for drug use disorders. Jim Carnes is the policy director for Alabama Arise, which advocates for low-income families. He said the state also needs to examine barriers to health care. “Of course we celebrate the improvements in Alabama’s rate, but there are some disturbing trends,” Carnes said, noting the persistent racial disparity and the number of births without prenatal care. While low-income women gain Medicaid coverage during pregnancy, they often don’t have care before or between pregnancies that could address chronic conditions or problems before they are pregnant, Carnes said. “That is something we could impact in a huge way with Medicaid expansion,” Carnes said. The Health Department said the leading causes of infant deaths in 2018 were congenital malformations, deformations and chromosomal abnormalities; disorders related to short gestation and low birth weight; sudden infant death syndrome and bacterial sepsis of newborns. These causes accounted for 50% of Alabama infant deaths.
[A]: Alabama infant mortality rate hits record low .


[Q]: Britain’s parliament last year voted to change the law to allow the three-parent in-vitro-fertilisation (IVF) technique known as mitochondrial transfer, which doctors say could help prevent incurable inherited diseases. The technique involves intervening in the fertilisation process to remove mitochondria, which act as tiny energy-generating batteries inside cells, and which, if faulty, can cause fatal heart problems, liver failure, brain disorders, blindness and muscular dystrophy. The treatment is known as “three-parent” IVF because the babies, born from genetically modified embryos, would have DNA from a mother, a father and from a female donor. Research teams around the world have tested and trialled the techniques in a series of pre-clinical experiments, but as yet they have not been used to treat patients in Britain. The world’s first and so-far only known mitochondrial transfer baby was born earlier this year after U.S. doctors working at a clinic in Mexico helped a Jordanian couple conceive using the new three-way treatment. In Britain, the Human Fertilisation and Embryology Authority (HFEA) will decide whether to issue the first licence to a clinic. It had convened an independent expert panel to explore current scientific evidence and offer recommendations. Publishing its conclusions on Wednesday, the panel said the techniques should now be approved by the HFEA for “cautious” use in “specific circumstances”. Various studies including one published in the journal Nature on Wednesday, have added to significant progress in the development of the techniques, the panel said, and they are “now at an acceptable stage for cautious clinical use”. Specialists welcomed the review’s recommendations. Robert Meadowcroft, chief executive of the charity Muscular Dystrophy UK, said the recommendations, if approved by the HFEA, would be “a major step towards the reality of offering an effective treatment to the 2,500 eligible women in the UK”. Darren Griffin, a professor of genetics at Kent University said that “in the current climate, where it seems that hype and hyperbole appear to outweigh measured decision making based on the facts, it’s pleasing to see a victory of common sense”. He said the review was good news for families at risk of transmitting mitochondrial disorders “and infinitely better than the alternative of children suffering with horrible diseases”.
[A]:
UK panel says new three-parent IVF technique now safe for 'cautious use'.